JAZZ - Jazz Pharmaceuticals PLC - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

JAZZ is currently covered by 21 analysts with an average price target of $163.03. This is a potential upside of $50.14 (44.41%) from yesterday's end of day stock price of $112.89.

Jazz Pharmaceuticals PLC's activity chart (see below) currently has 378 price targets and 340 ratings on display. The stock rating distribution of JAZZ is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.31% with an average time for these price targets to be met of 259.84 days.

Highest price target for JAZZ is $220, Lowest price target is $162, average price target is $192.

Most recent stock forecast was given by AMI FADIA from NEEDHAM on 10-Apr-2025. First documented stock forecast 31-May-2013.

Currently out of the existing stock ratings of JAZZ, 70 are a BUY (87.5%), 10 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$210

$99.2 (89.53%)

$210

18 days ago
(10-Apr-2025)

3/27 (11.11%)

$107.95 (105.78%)

190

Buy

$217

$106.2 (95.85%)

$200

1 months 18 days ago
(10-Mar-2025)

1/15 (6.67%)

$79.55 (57.88%)

176

Buy

$183

$72.2 (65.16%)

$175

1 months 21 days ago
(07-Mar-2025)

1/9 (11.11%)

$46.55 (34.12%)

210

Hold

$179

$68.2 (61.55%)

$128

1 months 21 days ago
(07-Mar-2025)

4/7 (57.14%)

$42.55 (31.18%)

227

Buy

$200

$89.2 (80.51%)

$200

2 months 1 days ago
(27-Feb-2025)

3/12 (25%)

$56.73 (39.60%)

589

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JAZZ (Jazz Pharmaceuticals PLC) average time for price targets to be met?

On average it took 259.84 days on average for the stock forecasts to be realized with a an average price target met ratio 37.31

Which analyst has the current highest performing score on JAZZ (Jazz Pharmaceuticals PLC) with a proven track record?

DAVID BUCK

Which analyst has the most public recommendations on JAZZ (Jazz Pharmaceuticals PLC)?

David Buck has 7 price targets and 12 ratings on JAZZ

Which analyst is the currently most bullish on JAZZ (Jazz Pharmaceuticals PLC)?

Annabel Samimy with highest potential upside - $119.2

Which analyst is the currently most reserved on JAZZ (Jazz Pharmaceuticals PLC)?

Irina Koffler with lowest potential downside - -$5

Jazz Pharmaceuticals PLC in the News

JAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell?

Share price of JAZZ Pharmaceuticals JAZZ hit $102.82 on Tuesday, close to its 52-week low of $99.06. This decline is attributable to the significant downturn in the broader biotech/drug sector due to the dynamic shifts in the regulatory landscape. While pharmaceuticals were initially exempted from tariffs in Trump’s ‘Liberation Day’ speech, he recently mentioned at...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?